Will Mercer
Story Poster
In the cards: Notre Dame stifles Tech, wins NCAA Tourney opener
2 yr ago by John Brice
After enduring a six-hour rain delay with a variety of card tricks, Notre Dame and Link Jarrett played all the right cards in a key opening win against Texas Tech
Story Poster
After near no-hitter caps Cambria title, No. 3 Irish ready for ACC play
2 yr ago by John Brice
Link Jarrett's powerhouse Fighting Irish program are still working out some early-season warts, particularly in their lineup, but Notre Dame keeps amassing wins -- 3 of them against Big Ten foes this weekend as ACC play looms Friday
Story Poster
Link Jarrett Q-and-A: Fall strides, changing perceptions, forging ahead
3 yr ago by John Brice
Notre Dame's third-year baseball coach carved some time out of his fall schedule to visit one-on-one with Irish Sports Daily. The opening part of his conversation with ISD follows here:
Story Poster
Irish ring up Huskies; 1 win from Super Regionals
3 yr ago by John Brice
No. 10 Notre Dame, the No. 1 seed in the South Bend Regional, continued its offensive and pitching clinic Saturday evening at Eck Stadium, battering UConn to come within one victory of a Super Regional berth.
Story Poster
Link Jarrett Notebook | Virginia Tech Win
3 yr ago by Matt Freeman
Notre Dame baseball coach Link Jarrett spoke following the 8-0 win over Virginia Tech in the ACC Championship.
Story Poster
Jarrett, Irish back to work with eyes on postseason prizes
3 yr ago by John Brice
No. 9-ranked Notre Dame plays its final ACC series of the baseball season beginning Thursday at Virginia Tech. Find out Link Jarrett's scouting report on the Hokies and why John Michael Bertrand is back starting Game 1 of the series for the Irish in a strategic move.
Story Poster
Link Jarrett Notebook | Game One Loss to Florida State
3 yr ago by Matt Freeman
Notre Dame baseball coach Link Jarrett spoke following the 5-2 loss to Florida State on Friday night.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.